Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

NCT05895994 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms
Hematologic Neoplasms
Neoplasms by Site
Hematologic Diseases

Interventions

DRUG: RD13-02 cell infusion

Sponsor

MEI HENG

Collaborators

[object Object]